As of Jan 13
| +0.09 / +1.97%|
The 3 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +115.05% increase from the last price of 4.65.
The current consensus among 3 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.